Pharmazz’s Lyfaquin, approved by DGCI, proves wonder in managing massive blood loss and hypovolemic shock January 12, 2021 The discovery of Lyfaquin as a resuscitative agent was made at Midwestern University in the USA and developed by Pharmazz to bring this product to the patient for the first time. The pharma major Pharmazz India has... Trending From IAS to UNIDO: Naresh Nandan Prasad’s Extraordinary Journey in ‘Small Cogs in a Large Wheel’ Chlorine disinfectant no more effective than water at killing hospital superbug: Study Center releases guidelines to reduce snakebite death by half by 2030 Latest ICMR starts first in-human clinical trials for Zika vaccine Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease NITI Ayog suggests separate legislation, fund for future pandemic Health ministry seeks action-taken report from hospitals on Kolkata incident
